Joseph D. Ruether

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · Journal of Clinical Oncology · 2009 · 2.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Double-Blinded Randomized Study of High-Dose Calcitriol Plus Docetaxel Compared With Placebo Plus Docetaxel in Androgen-Independent Prostate Cancer: A Report From the ASCENT Investigators

Tomasz M. Beer, Christopher W. Ryan, Peter Venner et al. · Journal of Clinical Oncology · 2007 · 310 citations · Full text

Medicine, Oncology, Urology +12

Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes

Jeffrey A. Russell, Hai T. Tran, Diana Quinlan et al. · Biology of Blood and Marrow Transplantation · 2002 · 290 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer

K.N. Chi, Susan Ellard, Sebastién J. Hotte et al. · Annals of Oncology · 2007 · 118 citations · Full text

Medicine, Oncology, Urology +13

C‐reactive protein as a prognostic marker for men with androgen‐independent prostate cancer

Tomasz M. Beer, Alshad S. Lalani, Stella Lee et al. · Cancer · 2008 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17